These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11708594)

  • 21. Cutaneous anthrax: an overview.
    Celia F
    Dermatol Nurs; 2002 Apr; 14(2):89-92. PubMed ID: 12017087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    JAMA; 2001 Dec; 286(23):2935-6. PubMed ID: 11787481
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(45):1024-6. PubMed ID: 12458919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inadvertent laboratory exposure to Bacillus anthracis--California, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(12):301-4. PubMed ID: 15800474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
    Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG
    Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anthrax in the era of biowarfare].
    Bossi P; Bricaire F
    Presse Med; 2003 Feb; 32(4):167-73. PubMed ID: 12610473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary anthrax].
    Debord T; Vidal D
    Rev Pneumol Clin; 1998 Dec; 54(6):377-81. PubMed ID: 10100352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846
    [No Abstract]   [Full Text] [Related]  

  • 34. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
    Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotics for anthrax: patient requests and physician prescribing practices during the 2001 New York City attacks.
    Hupert N; Chege W; Bearman GM; Pelzman FN
    Arch Intern Med; 2004 Oct; 164(18):2012-6. PubMed ID: 15477436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial therapy for anthrax.
    Torres-Tortosa M; Caballero-Granado FJ; Moreno I; Canueto J
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):696; author reply 697. PubMed ID: 12373508
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccines and bioterrorism: smallpox and anthrax.
    Kimmel SR; Mahoney MC; Zimmerman RK
    J Fam Pract; 2003 Jan; 52(1 Suppl):S56-61. PubMed ID: 12556279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition and management of anthrax--an update.
    Swartz MN
    N Engl J Med; 2001 Nov; 345(22):1621-6. PubMed ID: 11704686
    [No Abstract]   [Full Text] [Related]  

  • 39. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528
    [No Abstract]   [Full Text] [Related]  

  • 40. Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites--United States, 2001-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Sep; 51(35):786-9. PubMed ID: 12227440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.